Showing results (951-960 of 1,182) with videos related to
Sort By:
Pageof 119
Applied Health Economics and Health Policy|April 23, 2009
Does extending health insurance coverage to the uninsured improve population health outcomes?James A Thornton, Jennifer L RiceApplied Health Economics and Health Policy|February 24, 2009
Cost effectiveness of ultrasound and bone densitometry for osteoporosis screening in post-menopausal womenDirk Mueller, Afschin GandjourApplied Health Economics and Health Policy|February 24, 2009
Households' willingness to pay for a motorcycle helmet in Hanoi, VietnamKhanh H Pham, Quynh X Le Thi, Dennis J Petrie, et al.Applied Health Economics and Health Policy|February 24, 2010
Health system choice: a pilot discrete-choice experiment eliciting the preferences of British and Australian citizensPaul A Scuffham, Jennifer A Whitty, Matthew Taylor, et al.Applied Health Economics and Health Policy|February 24, 2010
Outpatient medication costs of patients with cystic fibrosis in GermanyDaniela Eidt-Koch, Thomas O F Wagner, Thomas Mittendorf, et al.Applied Health Economics and Health Policy|September 2, 2016
Economic Evaluation of Three Frequently Used Gonadotrophins in Assisted Reproduction Techniques in the Management of Infertility in the NetherlandsVassilis Fragoulakis, Chris P Pescott, Jesper M J Smeenk, et al.Applied Health Economics and Health Policy|November 29, 2005
Can privatising selected services benefit the public healthcare system?: the Greek caseDimitris Niakas, Mamas Theodorou, Lycurgus LiaropoulosApplied Health Economics and Health Policy|November 29, 2005
Barriers to the equitable funding of primary healthcare in South AfricaStephen Thomas, Okore A Okorafor, Sandi MbatshaApplied Health Economics and Health Policy|March 6, 2010
Public option and private profits: what do markets expect?Fabio MilaniApplied Health Economics and Health Policy|April 11, 2018
A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New ZealandLijoy Varghese, Louise Talbot, Andrea Govender, et al.Pageof 119